ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Exagen Inc

Exagen Inc (XGN)

4.80
-0.36
(-6.98%)
終了 2月11日 6:00AM
4.7994
-0.0006
(-0.01%)
取引時間後: 9:59AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
4.80
買値
4.75
売値
5.21
出来高
99,120
4.7202 日の範囲 5.35
1.3003 52 週間の範囲 6.21
時価総額
前日終値
5.16
始値
5.35
最終取引時間
財務取引量
US$ 488,507
VWAP
4.9284
平均取引量 (3 か月)
187,280
発行済株式数
17,637,278
配当利回り
-
PER
-3.57
1 株当たり利益 (EPS)
-1.34
歳入
52.55M
純利益
-23.69M

Exagen Inc について

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differentia... Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists. 詳細を表示

セクター
Medical Laboratories
業界
Medical Laboratories
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Exagen Inc is listed in the Medical Laboratories sector of the ナスダック市場 with ticker XGN. The last closing price for Exagen was US$5.16. Over the last year, Exagen shares have traded in a share price range of US$ 1.3003 to US$ 6.21.

Exagen currently has 17,637,278 shares in issue. The market capitalisation of Exagen is US$91.01 million. Exagen has a price to earnings ratio (PE ratio) of -3.57.

XGN 最新ニュース

Exagen Inc. to Participate in Upcoming Investor Conferences

CARLSBAD, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following...

Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results

New biomarkers on track for commercial launch in January 2025 Preliminary financial results indicate record full-year revenue and AVISE CTD trailing twelve-month ASP, with improvements to adjusted...

Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD

CARLSBAD, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Exagen Inc., a leading provider of autoimmune testing, today announced the completion of its 1,000,000th AVISE CTD test, marking a significant...

Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform

CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Exagen Inc., a leading provider of autoimmune testing, today announced the validation and regulatory submission for approval of new Systemic...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.930124.03421277043.86995.69923.863434015.08740967CS
41.6351.41955835963.175.69922.762111834.3758601CS
121.7456.8627450983.066.212.761872804.44077604CS
261.233.33333333333.66.212.381023154.15739185CS
522.7128.5714285712.16.211.3003728233.50027552CS
156-3.76-43.92523364498.569.441.3003512343.64119691CS
260-14.86-75.584944048819.6626.961.3003490227.76139613CS

XGN - Frequently Asked Questions (FAQ)

What is the current Exagen share price?
The current share price of Exagen is US$ 4.80
How many Exagen shares are in issue?
Exagen has 17,637,278 shares in issue
What is the market cap of Exagen?
The market capitalisation of Exagen is USD 91.01M
What is the 1 year trading range for Exagen share price?
Exagen has traded in the range of US$ 1.3003 to US$ 6.21 during the past year
What is the PE ratio of Exagen?
The price to earnings ratio of Exagen is -3.57
What is the cash to sales ratio of Exagen?
The cash to sales ratio of Exagen is 1.61
What is the reporting currency for Exagen?
Exagen reports financial results in USD
What is the latest annual turnover for Exagen?
The latest annual turnover of Exagen is USD 52.55M
What is the latest annual profit for Exagen?
The latest annual profit of Exagen is USD -23.69M
What is the registered address of Exagen?
The registered address for Exagen is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Exagen website address?
The website address for Exagen is www.exagen.com
Which industry sector does Exagen operate in?
Exagen operates in the MEDICAL LABORATORIES sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
CYNCYNGN Inc
US$ 0.1825
(203.16%)
2.09B
CSAICloudastructure Inc
US$ 12.3327
(128.81%)
10.25M
DOMHDominari Holdings Inc
US$ 6.17
(91.61%)
23.74M
MGOLMGO Global Inc
US$ 0.6996
(68.58%)
568.64M
BNAIBrand Engagement Network Inc
US$ 0.6802
(65.90%)
221.34M
PLRXPliant Therapeutics Inc
US$ 3.07
(-60.59%)
20.03M
CDTConduit Pharmaceuticals Inc
US$ 1.82
(-36.14%)
11M
MYNAMynaric AG
US$ 0.2563
(-33.31%)
1.54M
PSIGPS International Group Ltd
US$ 0.43
(-31.75%)
767.3k
SMTCSemtech Corp
US$ 37.58
(-31.06%)
19.35M
CYNCYNGN Inc
US$ 0.1825
(203.16%)
2.09B
MGOLMGO Global Inc
US$ 0.6996
(68.58%)
568.61M
OCEAOcean Biomedical Inc
US$ 0.148
(11.36%)
558.27M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0681
(26.11%)
284.95M
BNAIBrand Engagement Network Inc
US$ 0.6802
(65.90%)
221.34M

最近閲覧した銘柄

Delayed Upgrade Clock